XML 59 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1
Restructuring (Narrative) (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 21, 2017
USD ($)
open_position
Jul. 21, 2017
USD ($)
position
Jul. 21, 2017
USD ($)
Jan. 26, 2017
position
Oct. 31, 2016
USD ($)
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2016
position
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
Jun. 30, 2016
USD ($)
Restructuring Cost and Reserve [Line Items]                      
Impairment of intangible assets                   $ 586,232  
U.S. Generic Pharmaceuticals                      
Restructuring Cost and Reserve [Line Items]                      
Impairment of intangible assets           $ 268,200 $ 72,700        
Excess Inventory Reserve Write-Offs                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses           7,900          
Other Restructuring Costs                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses           16,000     $ 7,100 17,500 $ 11,800
2016 US Generic Pharmaceuticals Restructuring                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring costs incurred                 18,900 1,100 146,200
Restructuring expenses                   1,117  
2016 US Generic Pharmaceuticals Restructuring | Asset Impairment Charges                      
Restructuring Cost and Reserve [Line Items]                      
Impairment of intangible assets                     100,300
2016 US Generic Pharmaceuticals Restructuring | Excess Inventory Reserve Write-Offs                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses                 6,400   33,300
2016 US Generic Pharmaceuticals Restructuring | Employee Separation, Retention, and Other Benefit Related Costs | U.S. Generic Pharmaceuticals                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses                 6,400   6,400
2016 US Generic Pharmaceuticals Restructuring | Accelerated Depreciation | U.S. Generic Pharmaceuticals                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses                 3,400   3,400
2016 US Generic Pharmaceuticals Restructuring | Other Restructuring Costs | U.S. Generic Pharmaceuticals                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses                 $ 2,700   $ 2,700
2016 US Generic Pharmaceuticals Restructuring | Charlotte, North Carolina Facility                      
Restructuring Cost and Reserve [Line Items]                      
Proceeds from sale of property         $ 14,000            
2016 US Branded Pharmaceutical Restructuring                      
Restructuring Cost and Reserve [Line Items]                      
Number of positions reduced | position               375      
Expected restructuring costs remaining           0       0  
January 2017 Restructuring                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses                   15,060  
Expected number of positions to be eliminated | position       90              
Expected restructuring costs remaining           0       0  
January 2017 Restructuring | Corporate unallocated costs                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses                   4,900  
January 2017 Restructuring | U.S. Generic Pharmaceuticals | Operating Segments                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses                   3,300  
January 2017 Restructuring | U.S. Branded Pharmaceuticals | Operating Segments                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses                   6,900  
2017 US Generic Pharmaceuticals Restructuring                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses                   8,871  
2017 US Generic Pharmaceuticals Restructuring | Subsequent Event                      
Restructuring Cost and Reserve [Line Items]                      
Expected number of positions to be eliminated 35 875                  
Expected restructuring costs $ 325,000 $ 325,000 $ 325,000                
Estimated cash outlays     60,000                
2017 US Generic Pharmaceuticals Restructuring | U.S. Generic Pharmaceuticals                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses           109,300       109,300  
2017 US Generic Pharmaceuticals Restructuring | Asset Impairment Charges                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses           89,500       89,500  
2017 US Generic Pharmaceuticals Restructuring | Asset Impairment Charges | Subsequent Event                      
Restructuring Cost and Reserve [Line Items]                      
Expected restructuring costs 90,000 90,000 90,000                
2017 US Generic Pharmaceuticals Restructuring | Excess Inventory Reserve Write-Offs                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses           7,900       7,900  
2017 US Generic Pharmaceuticals Restructuring | Excess Inventory Reserve Write-Offs | Subsequent Event                      
Restructuring Cost and Reserve [Line Items]                      
Expected restructuring costs 10,000 10,000 10,000                
2017 US Generic Pharmaceuticals Restructuring | Employee Separation, Retention, and Other Benefit Related Costs | Subsequent Event                      
Restructuring Cost and Reserve [Line Items]                      
Expected restructuring costs 40,000 40,000 40,000                
2017 US Generic Pharmaceuticals Restructuring | Accelerated Depreciation | Subsequent Event                      
Restructuring Cost and Reserve [Line Items]                      
Expected restructuring costs 165,000 165,000 165,000                
2017 US Generic Pharmaceuticals Restructuring | Other Restructuring Costs                      
Restructuring Cost and Reserve [Line Items]                      
Restructuring expenses           $ 11,900       $ 11,900  
2017 US Generic Pharmaceuticals Restructuring | Other Restructuring Costs | Subsequent Event                      
Restructuring Cost and Reserve [Line Items]                      
Expected restructuring costs $ 20,000 $ 20,000 $ 20,000